| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $4.37B | -2.9% |
| Cost of Revenue | $1.51B | -14.1% |
| Gross Profit | $2.86B | +4.3% |
| R&D Expense | $1.17B | -13.7% |
| SG&A Expense | $1.09B | -32.3% |
| Operating Income | -$833.0M | +22.1% |
| Pre-tax Income | -$1.18B | -5.6% |
| Income Tax | $44.0M | +0.0% |
| Net Income | -$1.22B |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Short-term Investments | $93.0M | +1450.0% |
| Accounts Receivable | $735.0M | +0.1% |
| Inventory | $547.0M | -6.8% |
| Current Assets | $2.75B | +5.3% |
| Total Assets | $6.30B | -37.7% |
| Current Liabilities | $1.55B | -1.5% |
| Stockholders' Equity | $2.37B | -58.7% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $837.0M | +75.1% |
| Capital Expenditures | $128.0M | -34.4% |
| Investing Cash Flow | -$178.0M | +22.9% |
| Financing Cash Flow | -$570.0M | +52.9% |
| Free Cash Flow | $709.0M | +150.5% |
| -5.3% |
| EPS (Basic) | -$7.69 | -4.8% |
| EPS (Diluted) | -$7.69 | -4.8% |